Moleculin Biotech, Inc. MBRX

$0.61 +7.16% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K FORM 8-K 2026-08-14 View →
10-Q FORM 10-Q 2026-08-13 View →
4 FORM 4 2026-08-05 View →
4 FORM 4 2026-08-05 View →
4 FORM 4 2026-08-05 View →
8-K FORM 8-K 2026-08-03 View →
424B5 FORM 424B5 2026-08-03 View →
8-K FORM 8-K 2026-07-31 View →
S-1 FORM S-1 2026-07-29 View →
8-K FORM 8-K 2026-06-30 View →
8-K FORM 8-K 2026-06-30 View →
4 FORM 4 2026-06-24 View →
4 FORM 4 2026-06-24 View →
4 FORM 4 2026-06-24 View →
8-K FORM 8-K 2026-06-05 View →
8-K FORM 8-K 2026-05-29 View →
8-K FORM 8-K 2026-05-26 View →
8-K FORM 8-K 2026-05-22 View →
8-K FORM 8-K 2026-05-15 View →
10-Q FORM 10-Q 2026-05-14 View →
8-K FORM 8-K 2026-05-13 View →
8-K FORM 8-K 2026-05-12 View →
8-K FORM 8-K 2026-05-08 View →
8-K FORM 8-K 2026-04-23 View →
8-K FORM 8-K 2026-04-15 View →
S-3 FORM S-3 2026-03-27 View →
8-K FORM 8-K 2026-03-23 View →
8-K FORM 8-K 2026-03-19 View →
8-K FORM 8-K 2026-03-19 View →
10-K FORM 10-K 2026-03-18 View →
DEF 14A FORM DEF 14A 2026-03-09 View →
8-K FORM 8-K 2026-02-20 View →
8-K FORM 8-K 2026-02-18 View →
8-K FORM 8-K 2026-02-18 View →
8-K FORM 8-K 2026-02-17 View →
8-K FORM 8-K 2026-02-05 View →
8-K FORM 8-K 2026-01-20 View →
8-K FORM 8-K 2026-01-13 View →
8-K FORM 8-K 2026-01-12 View →
8-K FORM 8-K 2026-01-07 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.61
Market Cap
$4.35 million
52-Week Range
$0.16 – $24.00
Average Volume
1.58 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.